Thomson ReutersThe Wall Street Bull sculpture in lower Manhattan is seen facing up Broadway, two blocks south of where Dominique Strauss-Kahn is living under house arrestNEW YORK (Reuters) - U.S. stock index futures advanced on Monday, after the S&amp;P 500 notched its best weekly performance in almost two months, as oil prices continued to show signs of stabilizing. Futures snapshot at 7:35 a.m.: * S&amp;P 500 e-minis were up 4.25 points, or 0.21 percent, with 80,495 contracts changing hands. * Nasdaq 100 e-minis were up 8.5 points, or 0.2 percent, in volume of 14,883 contracts. * Dow e-minis &lt;1YMc1&gt; were up 45 points, or 0.25 percent, with 12,172 contracts changing hands. * Brent crude hit a high of $62.97 and WTI crude rose to as much as $58.53 amid investor confidence there would be no substantial price loss in the run-up to the new year. However, Brent pulled back to last trade down 14 cents to $61.24 while U.S. crude was last off 0.4 percent at $56.91. [O/R] * The benchmark S&amp;P index &lt;.SPX&gt; rose 3.4 percent last week, boosted by a 5 percent jump over three sessions, after the U.S. Federal Reserve said it would take a "patient" approach toward raising interest rates and as oil prices appeared to stabilize. The S&amp;P energy index &lt;.SPNY&gt; surged nearly 10 percent for the week. * Investors await existing home sales data, due out at 10:00 a.m. (1500 GMT). Expectations are for a decline of 1 percent. * Trading volume is expected to be light this week due to the Christmas holiday, which could increase volatility. U.S. equity markets will operate a shortened session on Wednesday and be closed on Thursday. * Gilead Sciences &lt;gild.o&gt; lost 6.6 percent to $101.30 in premarket trade. Express Scripts, the nation's largest pharmacy benefit manager, has lined up a cheaper price from AbbVie Inc &lt;abbv.n&gt; on its newly approved hepatitis C treatment and, in most cases, will no longer cover Gilead's treatments. * BioCryst Pharmaceuticals &lt;bcrx.o&gt; jumped 10.2 percent to $12.30 in light premarket trade after the U.S. Food and Drug Administration approved its intravenous flu drug. * Rising energy shares lifted European equities, while Greece's bourse advanced after its prime minister offered Sunday to bring pro-European independents into the government. [.EU] * Asian shares took their cues from Wall Street's strong finish last week and moved higher, also aided by the recovery in oil prices.   (Editing by Bernadette Baum) FREE AppDownload
